This topic contains a solution. Click here to go to the answer

Author Question: A patient with infertility will begin taking menotropins Repronex. The nurse will evaluate this ... (Read 14 times)

Kthamas

  • Hero Member
  • *****
  • Posts: 546
A patient with infertility will begin taking menotropins Repronex. The nurse will evaluate this patient's history to determine whether the:
 
  a. patient has a history of hyperinsulinemia.
  b. patient has excessive prolactin secretion.
  c. patient's pituitary can produce LH and FSH.
  d. patient's ovaries are capable of responding to gonadotropins.

Question 2

A patient has been diagnosed with multiple sclerosis (MS) for 10 years and has a history of 3 periods of neurologic dysfunction lasting several weeks separated by long periods of full recov-ery.
 
  In the past 6 months, the patient has had a prolonged period of neurologic dysfunction without remission. The nurse understands that the patient may have which MS subtype? a. Primary progressive MS
  b. Progressive-relapsing MS
  c. Relapsing-remitting MS
  d. Secondary progressive MS



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kbennett34

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

D
Menotropins are used when gonadotropin secretion by the pituitary is insufficient to provide adequate ovarian stimulation. Candidates must have ovaries capable of responding to FSH and LH. Metformin is used for hyperinsulinemia. Women with excessive prolactin secretion are treated with cabergoline. Menotropins contain equal amounts of LH and FSH and act directly on the ovaries, so the pituitary's inability to produce these hormones is not a factor for beginning treatment with this drug.

Answer to Question 2

D
Secondary progressive MS occurs when a patient with relapsing-remitting MS develops steadily worsening dysfunction with or without plateaus or acute exacerbations, or minor remissions. Within 10 to 20 years of onset, about 50 of patients with MS will develop this type. Primary progressive MS occurs when symptoms grow progressively more intense from the onset. Pro-gressive-relapsing MS is similar to primary progressive MS, but with acute exacerbations imposed on the steadily worsening symptoms. Relapsing-remitting MS is the most common initial presentation, which is characterized by recurrent, clearly defined episodes of symptoms with pe-riods of remission with relapse occurring approximately twice every 3 years.




Kthamas

  • Member
  • Posts: 546
Reply 2 on: Jul 23, 2018
:D TYSM


meow1234

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Excellent

 

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

For a complete list of videos, visit our video library